OncLive Insights

OncLive Insights

Series

All
All
Sandip P. Patel, MD, and Ticiana Leal, MD, experts on breast cancer

Targeting HER3 in Patients with Advanced NSCLC

Ticiana Leal, MD, and Sandip P. Patel, MD, discuss the treatment landscape for patients with advanced non–small cell lung cancer and the emerging role of targeting HER3.

Emerging Strategies in Multi-Cancer Early Detection

A panel of experts discusses the current landscape of multi-cancer early detection, addressing its potential to broaden access and improve cancer screening, emphasizing the importance of clinical trials and equitable healthcare distribution.

Inside The Clinic: HR+/HER2- Metastatic Breast Cancer

Virginia Kaklamani, MD, and Elizabeth Diaz, PA-C, discuss their approaches to the treatment and management of patients with HR-positive, HER2-negative metastatic breast cancer (HR+/HER2- mBC) in clinical practice.

Evolving Paradigms in the SCLC Treatment Landscape

Expert oncologists review updates in the treatment of small cell lung cancer that were presented at key conferences in 2022 and discuss data in the context the current treatment landscape.

Experts on MF

Inside the Clinic: Myelofibrosis

Experts from the John Theurer Cancer Center reflect on the real-world management of patients with myelofibrosis at their institution.

My Treatment Approach: Metastatic Castration-Resistant Prostate Cancer

Andrew Armstrong, MD, and Matthew Manning, MD, review the profiles of three patients with metastatic castration-resistant prostate cancer (mCRPC) and discuss how they would have approached their treatment, given recent advances in radiotherapy and other options in the field.